The encyclopedia · Strategy & Leadership · Operational decision · 2002–2006
GSK stopped leaking e-procurement savings by fixing compliance, not just tools
GSK's e-sourcing saved less than promised because staff bought off-contract; rebuilt information and compliance systems recovered 50% compliance in some areas.
GlaxoSmithKline
The solution
GlaxoSmithKline, like many companies, adopted e-sourcing tools and expected big procurement savings. The realized savings fell below predictions, and GSK traced the gap to noncompliant purchases — buying done outside contractual arrangements.
GSK estimated it was losing $80–120 million a year of procurement savings to noncompliance. The fix was not a better auction engine but a control problem: gather data on where compliance failed, identify why, and design conformance mechanisms.
GSK changed its information and compliance systems, and purchase compliance improved by 50 percent in some areas. The case distilled into a three-phase process — gathering data, identifying causes, designing conformance mechanisms — that other companies can reuse.
Why it worked
- The savings existed in contracts but leaked at execution
- Data made the size and location of noncompliance visible
- Redesigned systems made the compliant path the easy path
- Compliance was treated as a design problem, not a penalty problem
What can be applied
A tool only saves what people actually use: measure the gap between negotiated and executed purchases, find why buyers bypass the channel, then redesign information and controls around that behavior.
Aftermath
GSK's compliance framework became a reference for procurement analytics; the three-phase process is taught as the difference between signing savings and collecting them.
Sources
- Using Organizational Control Mechanisms to Enhance Procurement Efficiency: How GlaxoSmithKline Improved the Effectiveness of E-Procurement
- Using Organizational Control Mechanisms to Enhance Procurement Efficiency (abstract)
spotted an error? The archive wants to know.